ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AVO Aveon Group LP Com USD0.01

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Aveon Group LP Com USD0.01 NYSE:AVO NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Advanced Medical Optics Announces Release Date for First Quarter 2005 Operating Results

12/04/2005 6:10pm

PR Newswire (US)


Advanced medical Optics (NYSE:AVO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Advanced medical Optics Charts.
Advanced Medical Optics Announces Release Date for First Quarter 2005 Operating Results SANTA ANA, Calif., April 12 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE:AVO), a global leader in ophthalmic surgical devices and eye care products, today announced it will report first quarter 2005 financial results before the market opens on Thursday, April 28, 2005. (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO) The company will host a conference call and live web cast with investors and analysts on Thursday, April 28, 2005, at 10:00 a.m. EDT. To participate in the live Web cast or to access the archived replay, please visit AMO's Investors site at http://www.amo-inc.com/. About Advanced Medical Optics Advanced Medical Optics, Inc. (AMO) is a global leader in the development, manufacturing and marketing of ophthalmic surgical and eye care products. The company focuses on developing a broad suite of innovative technologies and devices to address a wide range of eye disorders. Products in the ophthalmic surgical line include intraocular lenses, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as Phacoflex(R), Clariflex(R), Array(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) and Vitrax(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 2,800 worldwide. The company has operations in about 20 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com/. Advanced Medical Optics, Inc. Investors: Sheree Aronson (714) 247-8290 http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO http://photoarchive.ap.org/ DATASOURCE: Advanced Medical Optics, Inc. CONTACT: Investors, Sheree Aronson of Advanced Medical Optics, Inc., +1-714-247-8290, Web site: http://www.amo-inc.com/

Copyright

1 Year Advanced medical Optics Chart

1 Year Advanced medical Optics Chart

1 Month Advanced medical Optics Chart

1 Month Advanced medical Optics Chart

Your Recent History